Study of InSpark Technologies' Pattern Identification System Published in the Journal of Diabetes Science and Technology - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Study of InSpark Technologies' Pattern Identification System Published in the Journal of Diabetes Science and Technology Data demonstrates the utility of InSpark's advanced blood glucose pattern recognition technology.


Study of InSpark Technologies' Pattern Identification System Published in the Journal of Diabetes Science and Technology

Data demonstrates the utility of InSpark's advanced blood glucose pattern recognition technology.

PR Newswire

CHARLOTTESVILLE, Va., July 7, 2014 /PRNewswire/ -- InSpark Technologies, Inc. announced today that the peer-reviewed Journal of Diabetes Science and Technology has published the paper "Evaluation of the Utility of a Glycemic Pattern Identification System" in its July 2014 issue. The system that is the subject of this paper is being incorporated into InSpark's Vigilant iPhone-enabled diabetes management software.

The retrospective study evaluated the Vigilantdaily pattern identification system in data from 536 patients with diabetes. It was found that patterns identified by Vigilant algorithms were predictive of future hyperglycemia and hypoglycemia across diabetes types and glycemic control groups, and were significantly more predictive than six other pattern identification techniques evaluated. Episodes of hypoglycemia, hyperglycemia, severe hypoglycemia, and severe hyperglycemia were 120 percent, 46 percent, 123 percent and 76 percent more likely in the next seven days after pattern identification, respectively, compared to intraday periods when no pattern was identified. Identified patterns continued to be predictive of glycemic events up to three months later.

"This is a significant validation of our technology platform," said Erik Otto, president and co-founder of InSpark Technologies. "An important measure of the utility of identified blood glucose patterns is the degree to which they are indicative of your risk of upcoming high or low blood glucose events. In this study we have shown that our pattern messages are not only highly predictive of future glycemic events, but more so than common ways glucose patterns are identified today. We are excited about bringing this technology to patients and clinicians so they can benefit from this pattern information to improve diabetes management."

"There are now many ways patients can transmit readings to mobile phones or cloud-based systems, but unfortunately little value is added to that data in terms of concise summaries or prospective actionable messages about glucose patterns," said Dr. Stacey Anderson, medical director at the University of Virginia Center for Diabetes Technology. "As shown by these study results, InSpark is taking a leadership role in transforming blood glucose data into relevant information that can empower patients and clinicians to make better diabetes management decisions in real-time."

Press Release Contact Information:
Marijean Jaggers
PR Consultant
Jaggers Communications
636-485-2920
mjaggers@jaggerscommunications.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.

Press Release URL:
http://www.webwire.com/ViewPressRel.asp?aId=189071

SOURCE InSpark Technologies

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document

Click here